111 related articles for article (PubMed ID: 26489581)
41. Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia.
Gotti E; Suter F; Baruzzo S; Perani V; Moioli F; Remuzzi G
Clin Transplant; 1996 Dec; 10(6 Pt 1):550-5. PubMed ID: 8996777
[TBL] [Abstract][Full Text] [Related]
42. Successful use of oral ganciclovir for the treatment of intrauterine cytomegalovirus infection in a renal allograft recipient.
Puliyanda DP; Silverman NS; Lehman D; Vo A; Bunnapradist S; Radha RK; Toyoda M; Jordan SC
Transpl Infect Dis; 2005 Jun; 7(2):71-4. PubMed ID: 16150094
[TBL] [Abstract][Full Text] [Related]
43. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J
Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888
[TBL] [Abstract][Full Text] [Related]
44. Rhabdomyolysis associated with cytomegalovirus infection in kidney transplant recipients.
Jung HY; Kim KH; Park SC; Lee JH; Choi JY; Cho JH; Park SH; Kim YL; Kim HK; Huh S; Kim CD
Transpl Infect Dis; 2014 Dec; 16(6):993-8. PubMed ID: 25251070
[TBL] [Abstract][Full Text] [Related]
45. Case study: rapid emergence of a cytomegalovirus UL97 mutant in a heart-transplant recipient on pre-emptive ganciclovir therapy.
Gilbert C; LeBlanc MH; Boivin G
Herpes; 2001 Nov; 8(3):80-2. PubMed ID: 11867025
[TBL] [Abstract][Full Text] [Related]
46. Ganciclovir treatment of systemic cytomegalovirus in an immunocompetent host.
Leman JS; Toalson TW; Wlodaver CG
J Okla State Med Assoc; 1997; 90(7):367-9. PubMed ID: 9379249
[TBL] [Abstract][Full Text] [Related]
47. [Current developments in the diagnosis and therapy of cytomegalovirus infections].
Bresser P; Toben FM; van Son WJ; Anema J; Beukhof JR
Ned Tijdschr Geneeskd; 1989 Mar; 133(9):455-7. PubMed ID: 2540441
[TBL] [Abstract][Full Text] [Related]
48. A case of destructive Wegener's granulomatosis complicated by cytomegalovirus infection.
Aries PM; Ullrich S; Gross WL
Nat Clin Pract Rheumatol; 2006 Sep; 2(9):511-5. PubMed ID: 16951706
[TBL] [Abstract][Full Text] [Related]
49. [Foscarnet therapy for ganciclovir-refractory cytomegalovirus hepatitis in a patient who underwent bone marrow transplantation from an unrelated donor].
Fujisaki T; Gondo H; Uchida N; Matsuo I; Takenaka K; Tanimoto K; Otsuka T; Minematsu T; Minamishima Y; Niho Y
Rinsho Ketsueki; 1997 Feb; 38(2):142-5. PubMed ID: 9059069
[TBL] [Abstract][Full Text] [Related]
50. Remission of IgA nephropathy following treatment of cytomegalovirus infection with ganciclovir.
Ortmanns A; Ittel TH; Schnitzler N; Handt S; Helmchen U; Sieberth G
Clin Nephrol; 1998 Jun; 49(6):379-84. PubMed ID: 9696435
[TBL] [Abstract][Full Text] [Related]
51. Recurrent cytomegalovirus colitis with megacolon in an immunocompetent elderly man.
Lin YH; Yeh CJ; Chen YJ; Chang MC; Su IH; Cheng HT
J Med Virol; 2010 Apr; 82(4):638-41. PubMed ID: 20166177
[TBL] [Abstract][Full Text] [Related]
52. Acute infection of Toxoplasma gondii and cytomegalovirus reactivation in a pediatric patient receiving liver transplant.
Galván Ramírez ML; Castillo-de-León Y; Espinoza-Oliva M; Bojorques-Ramos MC; Rodríguez-Pérez LR; Bernal Redondo R; Cañedo-Solares I; Espinoza López L; Correa D
Transpl Infect Dis; 2006 Dec; 8(4):233-6. PubMed ID: 17116139
[TBL] [Abstract][Full Text] [Related]
53. Residual esophageal cancer after neoadjuvant chemoradiotherapy frequently involves the mucosa and submucosa.
Shapiro J; ten Kate FJ; van Hagen P; Biermann K; Wijnhoven BP; van Lanschot JJ
Ann Surg; 2013 Nov; 258(5):678-88; discussion 688-9. PubMed ID: 24096766
[TBL] [Abstract][Full Text] [Related]
54. Clinical experience with ganciclovir and anti-cytomegalovirus immunoglobulin treatment for a severe case of congenital cytomegalovirus infection.
Weng YH; Chu SM; Lien RI; Chou YH; Lin TY
Chang Gung Med J; 2003 Feb; 26(2):128-32. PubMed ID: 12718390
[TBL] [Abstract][Full Text] [Related]
55. Late cytomegalovirus infection after oral ganciclovir prophylaxis in renal transplant recipients.
Murray BM; Subramaniam S
Transpl Infect Dis; 2004 Mar; 6(1):3-9. PubMed ID: 15225220
[TBL] [Abstract][Full Text] [Related]
56. Use of high-dose ganciclovir for a resistant cytomegalovirus infection due to UL97 mutation.
West P; Schmiedeskamp M; Neeley H; Oberholzer J; Benedetti E; Kaplan B
Transpl Infect Dis; 2008 Apr; 10(2):129-32. PubMed ID: 17605740
[TBL] [Abstract][Full Text] [Related]
57. Complete esophageal obliteration secondary to cytomegalovirus in AIDS patient.
Sheth A; Boktor M; Diamond K; Lavu K; Sangster G
Dis Esophagus; 2010 Aug; 23(6):E32-4. PubMed ID: 20659143
[TBL] [Abstract][Full Text] [Related]
58. Cytomegalovirus ileitis associated with goblet cell carcinoid tumour of the appendix.
Ng SC; Noursadeghi M; von Herbay A; Vaizey C; Pitcher MC; Flanagan KL
J Infect; 2007 Mar; 54(3):e153-6. PubMed ID: 17049463
[TBL] [Abstract][Full Text] [Related]
59. Is a 6-week course of ganciclovir therapy effective for chorioretinitis in infants with congenital cytomegalovirus infection?
Shoji K; Ito N; Ito Y; Inoue N; Adachi S; Fujimaru T; Nakamura T; Nishina S; Azuma N; Saitoh A
J Pediatr; 2010 Aug; 157(2):331-3. PubMed ID: 20400108
[TBL] [Abstract][Full Text] [Related]
60. Esophageal cancer complicated by cytomegalovirus esophagitis during chemoradiotherapy: case report.
Ohnuma H; Sato Y; Takayama T; Takimoto R; Abe T; Hagiwara S; Kukitsu T; Nobuoka A; Sato T; Kogawa K; Kato J; Niitsu Y
Gastrointest Endosc; 2003 Apr; 57(4):622-6. PubMed ID: 12665790
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
